BDBM34542 US8546380, 220::US8633188, 220

SMILES CC1(CCSC(N)=N1)c1cccc(c1)C(=O)Nc1ccc(Cl)cn1

InChI Key InChIKey=AKLATASKTPLNJX-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 34542   

TargetBeta-secretase 1(Human)
Shionogi

US Patent
LigandPNGBDBM34542(US8546380, 220 | US8633188, 220)
Affinity DataIC50: 1.50E+3nMAssay Description:Inhibition assay using beta-Secretase activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2013
Entry Details
Go to US Patent

TargetBeta-secretase 1(Human)
Shionogi

US Patent
LigandPNGBDBM34542(US8546380, 220 | US8633188, 220)
Affinity DataIC50: 1.50E+3nMpH: 5.0 T: 2°CAssay Description:Inhibition assay using beta-Secretase activity.More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2013
Entry Details
Go to US Patent

TargetBeta-secretase 1(Human)
Shionogi

US Patent
LigandPNGBDBM34542(US8546380, 220 | US8633188, 220)
Affinity DataIC50: 1.50E+3nMpH: 5.0 T: 2°CAssay Description:Zero point five μL of the test compounds (dissolved in N,N′-dimethylsulfoxide) were incubated with 48.5 μL of the fluorescence-quench...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2014
Entry Details
Go to US Patent

TargetBeta-secretase 1(Human)
Shionogi

US Patent
LigandPNGBDBM34542(US8546380, 220 | US8633188, 220)
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibition of recombinant human BACE1 (43 to 454 residues) expressed in Escherichia coli BL21 (DE3) using Biotin-XSEVNLDAEFRHDSGC-Eu fluorogenic pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed
TargetBeta-secretase 1(Human)
Shionogi

US Patent
LigandPNGBDBM34542(US8546380, 220 | US8633188, 220)
Affinity DataIC50: 170nMAssay Description:Inhibition of BACE1 in human SH-SY5Y cells expressing wild type betaAPP assessed as reduction in amyloidbeta (1 to 40 residues) level incubated for 2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/19/2022
Entry Details Article
PubMed